Deutsche Bank Reiterates €64.00 Price Target for Gerresheimer (GXI)

Deutsche Bank set a €64.00 ($76.19) price objective on Gerresheimer (ETR:GXI) in a research note released on Friday morning. The brokerage currently has a neutral rating on the stock.

GXI has been the topic of several other research reports. Credit Suisse Group set a €80.00 ($95.24) price objective on shares of Gerresheimer and gave the company a buy rating in a research report on Tuesday, October 10th. Goldman Sachs Group set a €69.50 ($82.74) price objective on shares of Gerresheimer and gave the company a neutral rating in a research report on Thursday, October 12th. Hauck & Aufhaeuser set a €63.50 ($75.60) price objective on shares of Gerresheimer and gave the company a neutral rating in a research report on Thursday, September 21st. set a €65.00 ($77.38) price objective on shares of Gerresheimer and gave the company a neutral rating in a research report on Tuesday, October 17th. Finally, Berenberg Bank set a €75.00 ($89.29) price objective on shares of Gerresheimer and gave the company a buy rating in a research report on Monday, September 4th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and five have given a buy rating to the company’s stock. The company has a consensus rating of Hold and a consensus price target of €72.64 ($86.48).

Shares of Gerresheimer (ETR GXI) opened at €66.13 ($78.73) on Friday. Gerresheimer has a 1 year low of €59.97 ($71.39) and a 1 year high of €78.25 ($93.15).

WARNING: This story was first reported by Community Financial News and is the sole property of of Community Financial News. If you are reading this story on another domain, it was stolen and reposted in violation of United States & international copyright law. The original version of this story can be accessed at https://www.com-unik.info/2017/12/04/deutsche-bank-reiterates-64-00-price-target-for-gerresheimer-gxi.html.

Gerresheimer Company Profile

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, such as inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.

Analyst Recommendations for Gerresheimer (ETR:GXI)

What are top analysts saying about Gerresheimer AG? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Gerresheimer AG and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit